Hyper-Care CAIHL draft report

HugoScore CAIHL Draft Report: Hyper-Care

Status: Draft for human review Last reviewed: 2026-06-30 Review method: Public-source review of Hyper-Care product, patients, advocacy, life-sciences, trust, values, FAQ, careers, and public demo app/source-map evidence; no account creation, real health-data connection, security audit, legal review, clinical review, or independent validation. Service: Hyper-Care Vendor: Hyper-Care, described publicly as a Public Benefit Corporation Category: Patient data collective and research matching AI

Summary

Hyper-Care presents itself as a patient data collective and community-driven health intelligence platform for rare, chronic, oncology, and underserved conditions. Public materials say patients can connect medical records, devices, surveys, claims, and genomic data; use AI tools for record understanding and care navigation; join community registries; match with studies; and receive compensation when data or participation supports research and development.

From a CAIHL perspective, Hyper-Care is potentially agency-expanding because the stated model centers patient data ownership, granular consent, visible partners, value sharing, and community-driven real-world evidence. The main caveat is that the same model also serves life sciences sponsors, CROs, researchers, advocacy organizations, payers, and providers. Patient agency depends on whether consent, key custody, revocation, compensation, sponsor visibility, and AI boundaries work as described.

Evidence Reviewed

• Hyper-Care homepage, refreshed 2026-06-30: https://hyper-care.org/
• Patients page, refreshed 2026-06-30: https://hyper-care.org/patients-1
• Advocacy page, refreshed 2026-06-30: https://hyper-care.org/advocacy
• Life Sciences page, refreshed 2026-06-30: https://hyper-care.org/life-sciences
• Trust page, refreshed 2026-06-30: https://hyper-care.org/trust-1
• FAQ, refreshed 2026-06-30: https://hyper-care.org/faq
• Values page, refreshed 2026-06-30: https://hyper-care.org/values
• Careers page, refreshed 2026-06-30: https://hyper-care.org/careers
• Public demo app and source-map strings, refreshed 2026-06-30: https://demo.hyper-care.org/

CAIHL Profile

• Who does this AI serve? Hybrid: patient-directed, advocacy-enabled, and life-sciences-facing. Hyper-Care is framed around patient control, but the platform also explicitly serves sponsors, CROs, researchers, providers, payers, and advocacy organizations.
• Can patients tell AI is involved? Yes. Public materials and demo strings describe safe AI, AI-powered care navigation, smart study matching, AI assistant prompts, and health-data analysis.
• Can patients meaningfully choose? Partial to yes, not verified. Public materials claim granular consent, explicit opt-in sharing, visible partners, and compensation, but actual consent screens, privacy/terms, revocation, sponsor contracts, and deletion workflows need review.
• Can patients correct or challenge what the AI produces? Partial / not disclosed. Public materials do not clearly describe how patients correct AI summaries, derived inferences, eligibility matches, or sponsor-facing data products.
• Does it help patients understand or act? Yes, if implemented as described. Claims include record organization, plain-language explanations, trend spotting, appointment preparation, care-team sharing, community support, and study matching.

Agency Interpretation

Hyper-Care's strongest agency move is trying to make patient data economically and operationally legible to patients and communities, not only to institutions. If the consent, pod, key, compensation, and partner-transparency claims are implemented well, the model could shift patients from passive data subjects into active stewards and research partners.

The unresolved issue is governance. Public pages claim patient-held encryption keys, Solid-style personal data pods, opt-in sharing, no scraping, aggregated insight monetization, AES-256 encryption, zero-knowledge cryptography, HIPAA/GDPR/SOC2/HITRUST alignment, and compensation. But public evidence did not include a full privacy policy, terms, BAA posture, certification proof, subprocessor list, retention/deletion rules, model-training policy, de-identification method, or revenue-sharing formula.

Key Unknowns

• Whether full privacy and terms documents exist and are patient-readable.
• Whether security/certification claims are independently audited or certified.
• How patient-held encryption keys and Solid pods work in practice.
• Whether patients can use core care-navigation features while refusing aggregated/de-identified insight products.
• How consent, revocation, deletion, sponsor visibility, and compensation are enforced.
• Which AI model providers process patient data and whether model training is prohibited.
• Whether study matching and eligibility logic can be challenged or corrected.
• Whether advertised recruitment, screen-failure, and attrition claims are validated.
• Whether accessibility, multilingual support, caregiver/proxy workflows, and low-literacy use have been tested.

Publication Recommendation

Ready for human review as a draft profile. Keep confidence low-to-medium until privacy/terms, certification evidence, encryption/key custody, consent and revocation screens, compensation mechanics, sponsor governance, clinical boundaries, accessibility, and independent deployment evidence are verified.